Matt Miksic

Stock Analyst at Barclays

(3.77)
# 724
Out of 5,044 analysts
293
Total ratings
59.92%
Success rate
4.72%
Average return

Stocks Rated by Matt Miksic

Stryker
Oct 22, 2025
Maintains: Overweight
Price Target: $443$453
Current: $375.93
Upside: +20.50%
Abbott Laboratories
Oct 17, 2025
Maintains: Overweight
Price Target: $159$162
Current: $126.61
Upside: +27.95%
GE HealthCare Technologies
Oct 13, 2025
Initiates: Equal-Weight
Price Target: $86
Current: $79.40
Upside: +8.31%
The Cooper Companies
Oct 13, 2025
Initiates: Overweight
Price Target: $85
Current: $71.75
Upside: +18.47%
Alcon
Oct 13, 2025
Initiates: Equal-Weight
Price Target: $86
Current: $74.82
Upside: +14.94%
Boston Scientific
Oct 2, 2025
Maintains: Overweight
Price Target: $133$136
Current: $100.97
Upside: +34.69%
Senseonics Holdings
Aug 27, 2025
Initiates: Overweight
Price Target: $30
Current: $7.20
Upside: +316.67%
Humacyte
Aug 27, 2025
Initiates: Overweight
Price Target: $3.5
Current: $1.70
Upside: +105.88%
LivaNova
Aug 21, 2025
Maintains: Equal-Weight
Price Target: $55$58
Current: $53.86
Upside: +7.69%
Insulet
Aug 21, 2025
Maintains: Equal-Weight
Price Target: $266$300
Current: $324.34
Upside: -7.50%
Maintains: Overweight
Price Target: $53$51
Current: $15.10
Upside: +237.75%
Maintains: Overweight
Price Target: $41$36
Current: $22.86
Upside: +57.48%
Maintains: Overweight
Price Target: $21$22
Current: $16.65
Upside: +32.13%
Maintains: Overweight
Price Target: $24$21
Current: $15.27
Upside: +37.52%
Maintains: Equal-Weight
Price Target: $93$98
Current: $69.23
Upside: +41.56%
Maintains: Overweight
Price Target: $90$95
Current: $82.19
Upside: +15.59%
Maintains: Equal-Weight
Price Target: $165$176
Current: $186.93
Upside: -5.85%
Maintains: Equal-Weight
Price Target: $19$16
Current: $15.20
Upside: +5.26%
Maintains: Overweight
Price Target: $261$241
Current: $184.21
Upside: +30.83%
Maintains: Overweight
Price Target: $16$12
Current: $3.79
Upside: +216.62%
Maintains: Overweight
Price Target: $684$635
Current: $545.39
Upside: +16.43%
Maintains: Overweight
Price Target: $100$103
Current: $62.75
Upside: +64.14%
Maintains: Underweight
Price Target: $118$112
Current: $101.14
Upside: +10.74%
Initiates: Overweight
Price Target: $22
Current: $4.82
Upside: +356.43%
Maintains: Overweight
Price Target: $105$109
Current: $93.23
Upside: +16.92%
Assumes: Outperform
Price Target: $100
Current: $63.21
Upside: +58.20%
Maintains: Outperform
Price Target: $722$418
Current: $133.14
Upside: +213.96%
Maintains: Outperform
Price Target: $31$28
Current: $16.56
Upside: +69.08%
Maintains: Outperform
Price Target: $68$67
Current: $13.07
Upside: +412.62%
Initiates: Outperform
Price Target: $480
Current: $5.75
Upside: +8,247.83%
Maintains: Outperform
Price Target: $84$87
Current: $15.56
Upside: +459.13%
Maintains: Outperform
Price Target: $24$25
Current: $4.19
Upside: +496.66%
Initiates: Sell
Price Target: $9
Current: $6.88
Upside: +30.81%